Paolo Fundaro, Director at INTERCEPT PHARMACEUTICALS INC (ICPT), sold 7,246 shares at $370.00 ($2.7M) on 2014-02-12, disclosed to the SEC on 2014-02-14.
Scheduled sale ($2.7M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $368.17 | 500 | $184K | 6.8% |
| 2 | $370.00 | 1,500 | $555K | 20.4% |
| 3 | $372.00 | 500 | $186K | 6.8% |
| 4 | $373.00 | 500 | $187K | 6.9% |
| 5 | $375.00 | 1,000 | $375K | 13.8% |
| 6 | $378.66 | 864 |
| $327K |
| 12.0% |
| 7 | $379.79 | 136 | $52K | 1.9% |
| 8 | $381.00 | 500 | $191K | 7.0% |
| 9 | $382.00 | 500 | $191K | 7.0% |
| 10 | $383.00 | 922 | $353K | 13.0% |
| 11 | $367.51 | 324 | $119K | 4.4% |
| Total | $375.26 avg | 7,246 | $2.7M | 100% |
| Filing → |
| ICPT | SELL | 2019-03-29 | $467K | — | Filing → |
| ICPT | SELL | 2015-07-24 | $166K | — | Filing → |
| ICPT | SELL | 2014-08-12 | $78K | — | Filing → |